Advertisement

Biotech in space?

Can the biotech and pharma make money in space? That was the question Congress posed at a hearing on the International Space Station's linkurl:future,;http://science.house.gov/press/PRArticle.aspx?NewsID=2167 held on Thursday (April 24). "I think I can," Tom Pickens, CEO of a spaceflight services company-turned biotech called SPACEHAB, told Congress. SPACEHAB has been sending up science payloads for the past 23 years. The company has mostly worked with government scientists, but when Pickens j

By | April 28, 2008

Can the biotech and pharma make money in space? That was the question Congress posed at a hearing on the International Space Station's linkurl:future,;http://science.house.gov/press/PRArticle.aspx?NewsID=2167 held on Thursday (April 24). "I think I can," Tom Pickens, CEO of a spaceflight services company-turned biotech called SPACEHAB, told Congress. SPACEHAB has been sending up science payloads for the past 23 years. The company has mostly worked with government scientists, but when Pickens joined in 2003 as a member of the board of directors, he had a team of engineers assess what kinds of research would be most commercially viable. To fit the bill, experiments had to be cheap to transport and provide an advantage - in efficiency, quality or capability - over what could be done on Earth. Two methods stood out: growing crystals for X-ray crystallography, and linkurl:vaccine production.;http://www.the-scientist.com/news/home/53627/ So SPACEHAB is going from space transport to drug discovery. The company's "first product will be a vaccine," said Pickens. But will investors bite? So far, said Bruce Pittman, a founding member of the Alliance of Commercial Enterprises and Education for Space, a group of pro-commercial space advocates, he hasn't seen any venture capital investment in this area, a fact that Pickens concedes. However, Pittman told The Scientist, "The stars are beginning to align." On April 18th, Space Florida, the state's aerospace development organization, announced that it would linkurl:partner;http://www.spacehab.com/news/2008/08_04_21.htm with SPACEHAB to help spur biotech in space, and awarded the company $90,000 in seed funding. The money will retroactively support infectious disease experiments SPACEHAB sent up in March 2008, and the follow-up experiment to be launched in May, to validate those experiments. Deb Spicer, spokeswoman for Space Florida, said that if the experiments are deemed successful, the agency plans to approve a larger contract, which is likely to be upwards of $100,000. (The exact amount has yet to be released.) Congress wants linkurl:verification;http://www.the-scientist.com/news/home/53389/ "from someone that's not the science community" that conducting life science research in space can be lucrative, Pickens said. "The American people want a return on investment."
Advertisement
Keystone Symposia
Keystone Symposia

Comments

Avatar of: Ellen Hunt

Ellen Hunt

Posts: 199

April 28, 2008

I can't imagine how microgravity could be an advantage for vaccines.
Avatar of: Elke Jahn

Elke Jahn

Posts: 1

April 30, 2008

Medicines may function in a completely different manner in space than on earth due to physiological changes (e.g. fluid shift). I think knowledge of the effects of drugs in a weightless environment are therefore essential to enable the safe and effective treatment of humans in space. Particularly when considering the fact that a growing number of them spend increasingly extended periods in space (tourists, flight to mars etc.)... \nDoes anyone know how drugs are tested before using them in Space?\n\n

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
NeuroScientistNews
NeuroScientistNews